Hip Hip Hi-Ray: New Highs for Dow, S&P 500; Nasdaq, Russell 2000 Jump
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
ALXN
Wider-than-Expected Loss at Orexigen in Q1
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
After The Biotech Sell-off, How Will Investors Treat Alexion Pharmaceuticals?
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
Acorda Misses on Earnings, Beats Revs
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
Regeneron Inks Ophthalmology Deal
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
New Data Detailing the Devastating Nature of Hypophosphatasia (HPP) and Treatment Effect of Asfotase Alfa in Infants, Young Children and Juveniles with HPP Presented at the Pediatric Academic Societies Meeting
[Business Wire] – Alexion Pharmaceuticals, Inc. today announced that researchers have presented new data from a large, retrospective, natural history study of patients with severe perinatal and infantile hypophosphatasia , an inherited, rare metabolic di moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to […]
Idenix’s Q1 Loss Widens
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
Why Alexion Pharmaceuticals (ALXN) could be an Impressive Growth Stock
moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to view […]
FDA Approves Conversion of Soliris® (eculizumab) Accelerated Approval in aHUS to Regular Approval for the Treatment of Patients with aHUS
[Business Wire] – Alexion Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved the Company’s supplemental Biologics License Application providing regular approval for Soliris® for the treatment of adult and pedia moreView todays social media effects on ALXNView the latest stocks trending across Twitter. Click to view dashboardSee who Alexion is hiring next, click here to […]
